Search

everythinglearnresearchcommunity

for

Search:↓

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Frontal Fibrosing Alopecia may be linked to autoimmune diseases like Sjögren's syndrome.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Women with PCOS can lead healthy lives with proper diagnosis and treatment.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

PCOS treatment should address both symptoms and metabolic risks, starting with lifestyle changes and possibly including medication.

Targeting hair follicles can effectively promote hair growth and treat hair disorders.

Spaceflight can harm skin health by altering gene expression, affecting DNA, mitochondria, and skin barriers.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Melatonin helped some Pomeranian dogs regrow hair, but it wasn't linked to estrogen receptors.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hair loss links to high blood pressure, high fat levels, and metabolic issues, suggesting early heart disease screening.

Early hair loss common in Chinese males, linked to family history and smoking; early treatment advised.

Caffeine can effectively treat hair loss and skin issues.

Neutered ferrets often develop hyperadrenocorticism, with symptoms like hair loss and lethargy, and androstenedione is a key indicator for diagnosis.

PCOS management involves medication, lifestyle changes, and personalized treatment to address symptoms and improve health.

Patients with acne vulgaris have lower serum irisin levels.